Clinical Trial Update: Comparison of Eplivanserin and Lormetazepam in the Treatment of Insomnia Characterized by Sleep Maintenance Difficulties [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing eplivanserin with lormetazepam for insomnia characterized by sleep maintenance difficulties has completed according to the update from…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• Eplivanserin (Eplivanserin)
• Lormetazepam (lormetazepam)

Snippet

Sponsor: Sanofi | Conditions: Sleep Initiation and Maintenance Disorders | Phase 3 | Status: COMPLETED